Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: February 18, 2026, 6:44 pm
Author: Getaka|Social: XLinkedIn

Insecticides India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: February 18, 2026, 6:44 pm

Market Cap 1,799 Cr.
Current Price 622
Intrinsic Value₹619.23
High / Low 1,098/532
Stock P/E13.3
Book Value 411
Dividend Yield0.32 %
ROCE17.2 %
ROE13.3 %
Face Value 10.0
PEG Ratio2.17

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Insecticides India Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Epigral Ltd 4,320 Cr. 1,002 2,114/90312.8 4870.60 %24.9 %22.3 % 10.0
Dharmaj Crop Guard Ltd 800 Cr. 236 391/16816.6 1310.00 %12.0 %9.28 % 10.0
Bhaskar Agrochemicals Ltd 63.9 Cr. 123 149/56.69.89 40.00.82 %21.3 %24.7 % 10.0
Bhagiradha Chemicals & Industries Ltd 2,720 Cr. 208 331/198112 54.90.07 %7.44 %4.91 % 1.00
Best Agrolife Ltd 649 Cr. 18.3 35.8/16.326.8 22.81.09 %12.9 %9.95 % 1.00
Industry Average10,789.40 Cr1,113.6828.55369.000.47%15.21%19.87%6.67

All Competitor Stocks of Insecticides India Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 356.53301.90639.95695.99357.94272.50656.69627.21359.23359.15691.37641.25383.56
Expenses 333.21330.22594.30613.71331.92263.24584.87537.35330.55330.68607.34556.38358.26
Operating Profit 23.32-28.3245.6582.2826.029.2671.8289.8628.6828.4784.0384.8725.30
OPM % 6.54%-9.38%7.13%11.82%7.27%3.40%10.94%14.33%7.98%7.93%12.15%13.24%6.60%
Other Income 0.370.413.89-0.171.234.562.541.540.212.943.752.670.89
Interest 4.844.473.172.862.792.071.621.681.402.023.654.084.61
Depreciation 6.436.656.887.357.427.607.137.237.557.147.289.279.34
Profit before tax 12.42-39.0339.4971.9017.044.1565.6182.4919.9422.2576.8574.1912.24
Tax % 24.80%-25.67%26.49%25.95%27.93%-94.70%25.10%25.31%24.77%36.94%25.43%25.45%27.70%
Net Profit 9.33-29.0129.0353.2412.278.0849.1461.6015.0014.0257.3055.318.84
EPS in Rs 3.15-9.809.8117.994.152.7316.6021.175.164.8219.6919.013.04

Last Updated: February 5, 2026, 12:39 pm

Below is a detailed analysis of the quarterly data for Insecticides India Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

  • For Sales, as of Dec 2025, the value is 383.56 Cr.. The value appears to be declining and may need further review. It has decreased from 641.25 Cr. (Sep 2025) to 383.56 Cr., marking a decrease of 257.69 Cr..
  • For Expenses, as of Dec 2025, the value is 358.26 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 556.38 Cr. (Sep 2025) to 358.26 Cr., marking a decrease of 198.12 Cr..
  • For Operating Profit, as of Dec 2025, the value is 25.30 Cr.. The value appears to be declining and may need further review. It has decreased from 84.87 Cr. (Sep 2025) to 25.30 Cr., marking a decrease of 59.57 Cr..
  • For OPM %, as of Dec 2025, the value is 6.60%. The value appears to be declining and may need further review. It has decreased from 13.24% (Sep 2025) to 6.60%, marking a decrease of 6.64%.
  • For Other Income, as of Dec 2025, the value is 0.89 Cr.. The value appears to be declining and may need further review. It has decreased from 2.67 Cr. (Sep 2025) to 0.89 Cr., marking a decrease of 1.78 Cr..
  • For Interest, as of Dec 2025, the value is 4.61 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.08 Cr. (Sep 2025) to 4.61 Cr., marking an increase of 0.53 Cr..
  • For Depreciation, as of Dec 2025, the value is 9.34 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.27 Cr. (Sep 2025) to 9.34 Cr., marking an increase of 0.07 Cr..
  • For Profit before tax, as of Dec 2025, the value is 12.24 Cr.. The value appears to be declining and may need further review. It has decreased from 74.19 Cr. (Sep 2025) to 12.24 Cr., marking a decrease of 61.95 Cr..
  • For Tax %, as of Dec 2025, the value is 27.70%. The value appears to be increasing, which may not be favorable. It has increased from 25.45% (Sep 2025) to 27.70%, marking an increase of 2.25%.
  • For Net Profit, as of Dec 2025, the value is 8.84 Cr.. The value appears to be declining and may need further review. It has decreased from 55.31 Cr. (Sep 2025) to 8.84 Cr., marking a decrease of 46.47 Cr..
  • For EPS in Rs, as of Dec 2025, the value is 3.04. The value appears to be declining and may need further review. It has decreased from 19.01 (Sep 2025) to 3.04, marking a decrease of 15.97.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 5:11 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 8018929069941,0731,1941,3631,4201,5041,8011,9662,0022,051
Expenses 7197818158809251,0061,2071,2681,3331,6791,8031,7831,825
Operating Profit 8211191114148188156153171122163219226
OPM % 10%12%10%11%14%16%11%11%11%7%8%11%11%
Other Income 0004302-23110710
Interest 27332620161524771311711
Depreciation 7141616172024252626292931
Profit before tax 4964508211815311011914184133190193
Tax % 18%15%21%28%29%20%22%22%24%25%23%27%
Net Profit 4055395984122869310763103140142
EPS in Rs 14.0119.2412.6719.1627.0939.4927.7530.1436.1621.2834.6748.0348.68
Dividend Payout % 10%0%11%7%5%3%10%4%6%14%9%4%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)37.50%-29.09%51.28%42.37%45.24%-29.51%8.14%15.05%-41.12%63.49%35.92%
Change in YoY Net Profit Growth (%)0.00%-66.59%80.37%-8.91%2.87%-74.75%37.65%6.91%-56.18%104.61%-27.57%

Insecticides India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:8%
5 Years:8%
3 Years:10%
TTM:3%
Compounded Profit Growth
10 Years:10%
5 Years:10%
3 Years:9%
TTM:21%
Stock Price CAGR
10 Years:12%
5 Years:20%
3 Years:8%
1 Year:-15%
Return on Equity
10 Years:13%
5 Years:11%
3 Years:10%
Last Year:13%

Last Updated: September 5, 2025, 7:40 am

Balance Sheet

Last Updated: December 4, 2025, 1:26 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 13132121212121212030302929
Reserves 2342793884445276417107988478869821,0531,167
Borrowings 2583222062371143051911005416387104242
Other Liabilities 287308322277338388372505473615611702536
Total Liabilities 7919219369781,0001,3551,2931,4241,3941,6941,7101,8881,973
Fixed Assets 170205194185232240239239253262283278380
CWIP 54385158171939599112314116181
Investments 11111111161210121315192629
Other Assets 5566676807257351,0841,0041,1151,0371,2931,2671,4221,483
Total Assets 7919219369781,0001,3551,2931,4241,3941,6941,7101,8881,973

Below is a detailed analysis of the balance sheet data for Insecticides India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
  • For Reserves, as of Sep 2025, the value is 1,167.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,053.00 Cr. (Mar 2025) to 1,167.00 Cr., marking an increase of 114.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 242.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 104.00 Cr. (Mar 2025) to 242.00 Cr., marking an increase of 138.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 536.00 Cr.. The value appears to be improving (decreasing). It has decreased from 702.00 Cr. (Mar 2025) to 536.00 Cr., marking a decrease of 166.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 1,973.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,888.00 Cr. (Mar 2025) to 1,973.00 Cr., marking an increase of 85.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 380.00 Cr.. The value appears strong and on an upward trend. It has increased from 278.00 Cr. (Mar 2025) to 380.00 Cr., marking an increase of 102.00 Cr..
  • For CWIP, as of Sep 2025, the value is 81.00 Cr.. The value appears to be declining and may need further review. It has decreased from 161.00 Cr. (Mar 2025) to 81.00 Cr., marking a decrease of 80.00 Cr..
  • For Investments, as of Sep 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 3.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 1,483.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,422.00 Cr. (Mar 2025) to 1,483.00 Cr., marking an increase of 61.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 1,973.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,888.00 Cr. (Mar 2025) to 1,973.00 Cr., marking an increase of 85.00 Cr..

Notably, the Reserves (1,167.00 Cr.) exceed the Borrowings (242.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 38-6854182-133242155135-1118595
Cash from Investing Activity + -57-33-19-14-26-49-24-1139-87-44-39
Cash from Financing Activity + 2336-639-143172-159-104-11580-98-62
Net Cash Flow 4-23-013-1159-6130-1843-6

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-176.00-211.00-115.00-123.0034.00-117.00-35.0053.00117.00-41.0076.00115.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 586884788075866570605570
Inventory Days 189220190232214355202248228247220265
Days Payable 12411811410812814196136117128114150
Cash Conversion Cycle 124170159201166289192177181178161185
Working Capital Days 1840758093116981081119299107
ROCE %16%17%12%16%20%21%14%15%16%10%13%17%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters 72.16%72.16%72.16%72.16%72.16%72.16%72.16%72.16%72.30%72.30%72.30%72.30%
FIIs 6.27%6.46%6.02%5.19%4.41%4.31%4.36%5.43%5.13%4.50%4.65%4.51%
DIIs 10.94%10.77%10.53%9.36%9.12%9.14%9.08%9.06%9.24%9.59%9.72%9.50%
Public 10.64%10.62%11.30%13.31%14.32%14.40%14.41%13.36%13.34%13.63%13.32%13.69%
No. of Shareholders 19,18916,35518,01218,86818,23219,25219,47422,48422,84922,68821,43622,336

Shareholding Pattern Chart

No. of Shareholders

Insecticides India Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Small Cap Fund 2,636,351 0.5 188.95N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 48.3834.5921.3654.1745.43
Diluted EPS (Rs.) 48.3834.5921.3654.1745.43
Cash EPS (Rs.) 58.6344.3630.1067.5957.14
Book Value[Excl.RevalReserv]/Share (Rs.) 372.74342.44310.26440.71396.93
Book Value[Incl.RevalReserv]/Share (Rs.) 372.74342.44310.26440.71396.93
Revenue From Operations / Share (Rs.) 687.32664.37608.60762.20687.17
PBDIT / Share (Rs.) 78.4358.1241.6188.1677.44
PBIT / Share (Rs.) 68.4148.2432.7974.8065.51
PBT / Share (Rs.) 66.0544.5628.2471.4457.59
Net Profit / Share (Rs.) 48.6134.4821.2854.2445.21
NP After MI And SOA / Share (Rs.) 48.8134.5921.3654.4445.43
PBDIT Margin (%) 11.418.746.8311.5611.26
PBIT Margin (%) 9.957.265.389.819.53
PBT Margin (%) 9.606.704.649.378.38
Net Profit Margin (%) 7.075.183.497.116.57
NP After MI And SOA Margin (%) 7.105.203.507.146.61
Return on Networth / Equity (%) 13.0910.096.8812.3511.44
Return on Capital Employeed (%) 17.7613.5010.3516.6116.09
Return On Assets (%) 7.485.973.727.696.58
Long Term Debt / Equity (X) 0.020.020.000.000.00
Total Debt / Equity (X) 0.090.080.170.050.11
Asset Turnover Ratio (%) 1.111.151.161.071.04
Current Ratio (X) 1.831.901.621.971.86
Quick Ratio (X) 0.690.670.480.730.72
Inventory Turnover Ratio (X) 2.361.601.881.611.77
Dividend Payout Ratio (NP) (%) 4.168.6723.410.004.40
Dividend Payout Ratio (CP) (%) 3.456.7416.560.003.48
Earning Retention Ratio (%) 95.8491.3376.590.0095.60
Cash Earning Retention Ratio (%) 96.5593.2683.440.0096.52
Interest Coverage Ratio (X) 33.2515.809.1626.2224.06
Interest Coverage Ratio (Post Tax) (X) 21.6110.375.6817.1316.51
Enterprise Value (Cr.) 1764.961468.531522.181224.20990.06
EV / Net Operating Revenue (X) 0.880.740.840.810.69
EV / EBITDA (X) 7.738.5412.367.046.19
MarketCap / Net Operating Revenue (X) 0.860.730.760.800.68
Retention Ratios (%) 95.8391.3276.580.0095.59
Price / BV (X) 1.591.431.511.391.19
Price / Net Operating Revenue (X) 0.860.730.760.800.68
EarningsYield 0.080.070.040.080.09

After reviewing the key financial ratios for Insecticides India Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 48.38. This value is within the healthy range. It has increased from 34.59 (Mar 24) to 48.38, marking an increase of 13.79.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 48.38. This value is within the healthy range. It has increased from 34.59 (Mar 24) to 48.38, marking an increase of 13.79.
  • For Cash EPS (Rs.), as of Mar 25, the value is 58.63. This value is within the healthy range. It has increased from 44.36 (Mar 24) to 58.63, marking an increase of 14.27.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 372.74. It has increased from 342.44 (Mar 24) to 372.74, marking an increase of 30.30.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 372.74. It has increased from 342.44 (Mar 24) to 372.74, marking an increase of 30.30.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 687.32. It has increased from 664.37 (Mar 24) to 687.32, marking an increase of 22.95.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 78.43. This value is within the healthy range. It has increased from 58.12 (Mar 24) to 78.43, marking an increase of 20.31.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 68.41. This value is within the healthy range. It has increased from 48.24 (Mar 24) to 68.41, marking an increase of 20.17.
  • For PBT / Share (Rs.), as of Mar 25, the value is 66.05. This value is within the healthy range. It has increased from 44.56 (Mar 24) to 66.05, marking an increase of 21.49.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 48.61. This value is within the healthy range. It has increased from 34.48 (Mar 24) to 48.61, marking an increase of 14.13.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 48.81. This value is within the healthy range. It has increased from 34.59 (Mar 24) to 48.81, marking an increase of 14.22.
  • For PBDIT Margin (%), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 8.74 (Mar 24) to 11.41, marking an increase of 2.67.
  • For PBIT Margin (%), as of Mar 25, the value is 9.95. This value is below the healthy minimum of 10. It has increased from 7.26 (Mar 24) to 9.95, marking an increase of 2.69.
  • For PBT Margin (%), as of Mar 25, the value is 9.60. This value is below the healthy minimum of 10. It has increased from 6.70 (Mar 24) to 9.60, marking an increase of 2.90.
  • For Net Profit Margin (%), as of Mar 25, the value is 7.07. This value is within the healthy range. It has increased from 5.18 (Mar 24) to 7.07, marking an increase of 1.89.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.10. This value is below the healthy minimum of 8. It has increased from 5.20 (Mar 24) to 7.10, marking an increase of 1.90.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 13.09. This value is below the healthy minimum of 15. It has increased from 10.09 (Mar 24) to 13.09, marking an increase of 3.00.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 17.76. This value is within the healthy range. It has increased from 13.50 (Mar 24) to 17.76, marking an increase of 4.26.
  • For Return On Assets (%), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 5.97 (Mar 24) to 7.48, marking an increase of 1.51.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.02.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. It has increased from 0.08 (Mar 24) to 0.09, marking an increase of 0.01.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 1.11. It has decreased from 1.15 (Mar 24) to 1.11, marking a decrease of 0.04.
  • For Current Ratio (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 1.90 (Mar 24) to 1.83, marking a decrease of 0.07.
  • For Quick Ratio (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 24) to 0.69, marking an increase of 0.02.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 4. It has increased from 1.60 (Mar 24) to 2.36, marking an increase of 0.76.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.16. This value is below the healthy minimum of 20. It has decreased from 8.67 (Mar 24) to 4.16, marking a decrease of 4.51.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.45. This value is below the healthy minimum of 20. It has decreased from 6.74 (Mar 24) to 3.45, marking a decrease of 3.29.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 95.84. This value exceeds the healthy maximum of 70. It has increased from 91.33 (Mar 24) to 95.84, marking an increase of 4.51.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.55. This value exceeds the healthy maximum of 70. It has increased from 93.26 (Mar 24) to 96.55, marking an increase of 3.29.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 33.25. This value is within the healthy range. It has increased from 15.80 (Mar 24) to 33.25, marking an increase of 17.45.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 21.61. This value is within the healthy range. It has increased from 10.37 (Mar 24) to 21.61, marking an increase of 11.24.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 1,764.96. It has increased from 1,468.53 (Mar 24) to 1,764.96, marking an increase of 296.43.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has increased from 0.74 (Mar 24) to 0.88, marking an increase of 0.14.
  • For EV / EBITDA (X), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 8.54 (Mar 24) to 7.73, marking a decrease of 0.81.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 24) to 0.86, marking an increase of 0.13.
  • For Retention Ratios (%), as of Mar 25, the value is 95.83. This value exceeds the healthy maximum of 70. It has increased from 91.32 (Mar 24) to 95.83, marking an increase of 4.51.
  • For Price / BV (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has increased from 1.43 (Mar 24) to 1.59, marking an increase of 0.16.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 24) to 0.86, marking an increase of 0.13.
  • For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 24) to 0.08, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Insecticides India Ltd as of February 18, 2026 is: ₹583.48

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 18, 2026, Insecticides India Ltd is Overvalued by 6.19% compared to the current share price ₹622.00

Intrinsic Value of Insecticides India Ltd as of February 18, 2026 is: ₹619.23

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 18, 2026, Insecticides India Ltd is Overvalued by 0.45% compared to the current share price ₹622.00

Last 5 Year EPS CAGR: 6.13%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 15.58%, which is a positive sign.
  2. The company has higher reserves (688.92 cr) compared to borrowings (183.31 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (277.23 cr) and profit (114.31 cr) over the years.
  1. The stock has a high average Working Capital Days of 86.42, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 181.92, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Insecticides India Ltd:
    1. Net Profit Margin: 7.07%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 17.76% (Industry Average ROCE: 15.21%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 13.09% (Industry Average ROE: 19.87%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 21.61
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.69
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 13.3 (Industry average Stock P/E: 28.55)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.09
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Insecticides (India) Ltd. is a Public Limited Listed company incorporated on 18/12/1996 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L65991DL1996PLC083909 and registration number is 083909. Currently Company is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company's Total Operating Revenue is Rs. 2002.27 Cr. and Equity Capital is Rs. 29.10 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Agro Chemicals/Pesticides401-402, Lusa Tower, Delhi Delhi 110033Contact not found
Management
NamePosition Held
Mr. Hari Chand AggarwalChairman & Wholetime Director
Mr. Rajesh Kumar AggarwalManaging Director
Mr. Nikunj AggarwalWhole Time Director
Mr. Anil Kumar GoyalWhole Time Director
Ms. Praveen GuptaIndependent Director
Mr. Anil Kumar BhatiaIndependent Director
Mr. Shyam Lal BansalIndependent Director
Mr. Supratim BandyopadhayIndependent Director

FAQ

What is the intrinsic value of Insecticides India Ltd?

Insecticides India Ltd's intrinsic value (as of 18 February 2026) is ₹619.23 which is 0.45% lower the current market price of ₹622.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,799 Cr. market cap, FY2025-2026 high/low of ₹1,098/532, reserves of ₹1,167 Cr, and liabilities of ₹1,973 Cr.

What is the Market Cap of Insecticides India Ltd?

The Market Cap of Insecticides India Ltd is 1,799 Cr..

What is the current Stock Price of Insecticides India Ltd as on 18 February 2026?

The current stock price of Insecticides India Ltd as on 18 February 2026 is ₹622.

What is the High / Low of Insecticides India Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Insecticides India Ltd stocks is ₹1,098/532.

What is the Stock P/E of Insecticides India Ltd?

The Stock P/E of Insecticides India Ltd is 13.3.

What is the Book Value of Insecticides India Ltd?

The Book Value of Insecticides India Ltd is 411.

What is the Dividend Yield of Insecticides India Ltd?

The Dividend Yield of Insecticides India Ltd is 0.32 %.

What is the ROCE of Insecticides India Ltd?

The ROCE of Insecticides India Ltd is 17.2 %.

What is the ROE of Insecticides India Ltd?

The ROE of Insecticides India Ltd is 13.3 %.

What is the Face Value of Insecticides India Ltd?

The Face Value of Insecticides India Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Insecticides India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports